miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets.
about
Mpl traffics to the cell surface through conventional and unconventional routesMicroRNAs in platelet production and activationThe Role of MicroRNAs in Myeloproliferative NeoplasiaGenomic landscape of megakaryopoiesis and platelet function defectsThe proto-oncogene TWIST1 is regulated by microRNAsPlatelet microRNA-mRNA coexpression profiles correlate with platelet reactivity.Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.Thrombopoietin and hematopoietic stem cells.The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin.The miRNA Profile of Platelets Stored in a Blood Bank and Its Relation to Cellular Damage from Storage.MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes.MiR-28 regulates Nrf2 expression through a Keap1-independent mechanismStrand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cellsA novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer.miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection.MicroRNA expression differences in human hematopoietic cell lineages enable regulated transgene expression.Identification of Target Genes Involved in Wound Healing Angiogenesis of Endothelial Cells with the Treatment of a Chinese 2-Herb FormulaMiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO.MicroRNA Expression Analysis in Patients with Primary Myelofibrosis, Polycythemia vera and Essential Thrombocythemia.MicroRNAs and other non-coding RNAs as targets for anticancer drug development.Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.Unveiling the principle of microRNA-mediated redundancy in cellular pathway regulationOrbId: Origin-based identification of microRNA targetsSystematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms.Exosomal cell-to-cell transmission of alpha synuclein oligomers.miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemiaGenetic dissection of platelet function in health and disease using systems biology.MicroRNAs as Haematopoiesis Regulators.MicroRNAs in myeloproliferative neoplasms.miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives.MicroRNAs in the midst of myeloid signal transduction.microRNA regulation in megakaryocytopoiesis.Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets.MicroRNAs in platelet production and activation.Hematological malignancies: role of miRNAs and their in silico aspects.The JAK-STAT pathway and hematopoietic stem cells from the JAK2 V617F perspective.microRNAs: role in leukemia and their computational perspective.miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation.
P2860
Q24299221-A7D63B3B-AA74-4C0D-B32E-67251E2B1780Q24622537-29ACDBC2-65D8-44F1-8C8D-8601E0BD65E3Q26739435-6288104A-B21E-4C0C-9B69-DFC2FA1184A8Q26770869-9C56861B-FF37-4D6B-9DDA-84DABA348580Q28533475-ABA170DD-5EA3-4EC7-BB36-855D3645B991Q30500885-48981ED6-24F4-4567-8F04-5D3264EF19A5Q30847181-2A4EF02C-6D0C-45D7-8D2B-50148E3F909EQ33394846-9903836A-9A79-4B6B-A680-6AD348A88100Q33440994-835E60AF-6267-4822-9C5C-F538341C739BQ33457486-819A4FA7-357D-4217-881D-E1AAE20003C2Q33730792-C44EA01C-1D0A-4E6A-9FDF-7C6B3C800DA1Q34173401-43704682-DD6F-449B-A4C9-ED3B8A801C44Q34189586-3A188CB0-6CE3-4541-8562-7613B54668CCQ34246676-6F19E3CA-4804-4CDA-BC80-9B10A88DD054Q35101278-6F9176FF-BD18-448B-83F8-D38CD696FD0FQ35126591-C77B4DC3-7F8F-4C6E-BA0B-14260DF72662Q35207667-AA80EF5A-F87F-495C-A58E-6B12C7FB7ABDQ35796599-8FD4C34B-786B-4A81-97B6-30BE42DC6C2BQ35962533-7A7BAFC2-6EF1-4A1D-BBC7-D6F007BA0094Q35975009-CE9E574D-C258-4468-B782-6045ED2B7B89Q35994443-FB0D26C5-AAE5-4323-9F29-FC87F86ED09AQ36001930-C5EFED17-9779-4F39-90B7-91920BE8F52FQ36191693-73B02E4C-BAFE-4510-AEF2-B4C0785756C1Q36312053-D70D13A6-EE4D-4E06-B0E2-7620D8C9F4A1Q36352553-F7260D9C-05F9-45CA-BF93-1FE9FE160AFBQ36353854-06490F77-287F-49BF-B5BE-4A363A5B0364Q36754808-D8ABB011-F1CD-4766-8077-EBDE63A98A4AQ37156517-5226B69A-F09B-458E-ABD0-1A75E4C65D8AQ37448597-17AC7052-CA02-413D-BE08-0BE0C6DAC9E4Q37529812-5AB02058-357E-4EC3-90F0-12BFFD37AE09Q37687490-7D2FF8A3-2FCA-40CD-AD1C-A5F3D243E99AQ37724614-D88A6862-C366-4BB7-ADE8-98A7F0D87FABQ37875000-6A68AA8B-8932-464C-AF0E-38AB9C9BA3B7Q37930701-44C1C000-90C1-4759-B3FC-9E92C2B94FB2Q38044999-09BFE007-6DBA-4E7A-8F6F-34551955E2F1Q38117746-3C1ABCC8-A0D5-4546-91A2-30D82A391BCAQ38140001-B143A84D-ACAF-4F1D-8FB8-B5A25FFC0309Q38140890-17A75D05-E197-4486-B682-DAF2BE7BB9EAQ38240767-8085765C-8EFB-41A4-86CE-E99C87A30349Q38322947-7C5B49D4-01BB-4CE5-954C-55A73EDE2D32
P2860
miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
miR-28 is a thrombopoietin rec ...... ve neoplasm patient platelets.
@ast
miR-28 is a thrombopoietin rec ...... ve neoplasm patient platelets.
@en
miR-28 is a thrombopoietin rec ...... ve neoplasm patient platelets.
@nl
type
label
miR-28 is a thrombopoietin rec ...... ve neoplasm patient platelets.
@ast
miR-28 is a thrombopoietin rec ...... ve neoplasm patient platelets.
@en
miR-28 is a thrombopoietin rec ...... ve neoplasm patient platelets.
@nl
prefLabel
miR-28 is a thrombopoietin rec ...... ve neoplasm patient platelets.
@ast
miR-28 is a thrombopoietin rec ...... ve neoplasm patient platelets.
@en
miR-28 is a thrombopoietin rec ...... ve neoplasm patient platelets.
@nl
P2093
P1433
P1476
miR-28 is a thrombopoietin rec ...... ive neoplasm patient platelets
@en
P2093
Augustin Ferrant
Christian Pecquet
Laurent Knoops
Michael Girardot
Siham Boukour
Stéphane Giraudier
P304
P356
10.1182/BLOOD-2008-06-165985
P407
P577
2010-05-05T00:00:00Z